SKI Market

A+| A| A-|

Indian Indices

Sensex

73,134.32 1,186.77
( 1.65%)

Global Indices

Nasdaq

46,363.90 1,126.75
(2.49%)

Dow Jones

6,550.24 185.52
(2.91%)

Hang Seng

53,589.67 2,525.95
(4.95%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

94.31 -0.22
(-0.23%)

EUR-INR

108.30 -0.48
(-0.44%)

GBP-INR

124.69 -0.63
(-0.50%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

59.9554673

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

23.2

2858.61

EPS(TTM)

Face Value()

Div & Yield %

11.01

2.04

Back

hindustan unilever ltd

Auri Grow India reports standalone net loss of Rs 0.29 crore in the September 2025 quarter

Nov 15,2025

Net loss of Auri Grow India reported to Rs 0.29 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales declined 90.36% to Rs 8.00 crore in the quarter ended September 2025 as against Rs 83.03 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8.00	83.03	-90
OPM %	-0.38	1.11	-
PBDT	-0.24	0.88	PL
PBT	-0.39	0.77	PL
NP	-0.29	0.70	PL

73,134.32 1,186.77 ( 1.65%)

46,363.90 1,126.75 (2.49%)

6,550.24 185.52 (2.91%)

53,589.67 2,525.95 (4.95%)

10,364.79 188.34 (1.85%)

94.31 -0.22 (-0.23%)

108.30 -0.48 (-0.44%)

124.69 -0.63 (-0.50%)

0.59 0.00 (0.19%)